DFTX Q1 2024 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

Q1 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$527,000

Operating Income

-$22M

Net Income

-$54M

EPS (Diluted)

$-1.14

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$276M

Total Liabilities

$79M

Stockholders' Equity

$196M

Cash & Equivalents

$252M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$527,000	$0	—
Operating Income	-$22M	-$21M	-6.4%
Net Income	-$54M	-$25M	-119.2%